Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Vasculitis | Case report

A rare case of renal infarction due to heroin and amphetamine abuse: case report

Authors: Suhail Khokhar, Daniela Garcia, Rajesh Thirumaran

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

Renal infarctions as a result of recreational drug use are rare and are commonly associated with cocaine use. Although amphetamines have a similar mechanism of action as cocaine, there are few reports linking them to ischemic events, and only one to renal infarction. Similarly, few reports link heroin use with infarcts, but never in the kidney. Although uncommon, several mechanisms have been implicated in heroin and amphetamine-induced infarction, including vasculopathy, vasculitis and the activation of the coagulation cascade.

Case Presentation

47-year-old female with a past medical history of non-intravenous heroin and amphetamine abuse, chronic obstructive pulmonary disease, hypertension, hyperlipidemia presented with right lower extremity swelling and rash, which was diagnosed as cellulitis and treated appropriately. Incidentally, the patient was found to have an acute kidney injury and further workup identified multiple renal infarcts in the right kidney. The patient had no past medical history of clotting disorders. Blood culture and urine cultures were sterile; autoimmune and hypercoagulable workup were negative. Urinalysis was unremarkable. Urine toxicology was only positive for opiates and amphetamines, which were thought to be the most likely cause of the renal infarct. Patient was lost to outpatient follow up due to noncompliance, but returned to the hospital for re-emergence of her cellulitis, during which no new infarcts were discovered, and the previous renal infarct had scarred over.

Conclusion

There are very few reports of heroin and amphetamine-induced infarctions. This case report describes a rare but important complication of heroin/amphetamine abuse that could be easily overlooked.
Literature
1.
go back to reference Adle-Biassette H, et al. Cerebral infarctions in a drug addict inhaling heroin. Arch Anat Cytol Pathol. 1996;44(1):12–7.PubMed Adle-Biassette H, et al. Cerebral infarctions in a drug addict inhaling heroin. Arch Anat Cytol Pathol. 1996;44(1):12–7.PubMed
2.
go back to reference Antopolsky M, et al. Renal infarction in the ED: 10-year experience and review of the literature. Am J Emerg Med. 2012;30(7):1055–60.CrossRef Antopolsky M, et al. Renal infarction in the ED: 10-year experience and review of the literature. Am J Emerg Med. 2012;30(7):1055–60.CrossRef
3.
go back to reference Bingham C, et al. Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3, 4-methylenedioxymethamphetamine ('ecstasy'). Nephrol Dial Transplant. 1998;13(10):2654–5.CrossRef Bingham C, et al. Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3, 4-methylenedioxymethamphetamine ('ecstasy'). Nephrol Dial Transplant. 1998;13(10):2654–5.CrossRef
4.
go back to reference Bolz J, et al. Multiple cerebral infarctions in a young patient with heroin-induced hypereosinophilic syndrome. J Neurol Sci. 2015;356(1):193–5.CrossRef Bolz J, et al. Multiple cerebral infarctions in a young patient with heroin-induced hypereosinophilic syndrome. J Neurol Sci. 2015;356(1):193–5.CrossRef
5.
go back to reference Bose, J., et al. "Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2017 national survey on drug use and health." (2018). Bose, J., et al. "Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2017 national survey on drug use and health." (2018).
6.
go back to reference Bourgault M, et al. Acute renal infarction: a case series. Clin J Am Soc Nephrol. 2013;8(3):392–8.CrossRef Bourgault M, et al. Acute renal infarction: a case series. Clin J Am Soc Nephrol. 2013;8(3):392–8.CrossRef
7.
go back to reference de Ligny BH, et al. Early loss of two renal grafts obtained from the same donor: role of ecstasy? Transplantation. 2005;80(1):153–6.CrossRef de Ligny BH, et al. Early loss of two renal grafts obtained from the same donor: role of ecstasy? Transplantation. 2005;80(1):153–6.CrossRef
8.
go back to reference Silva D, Anne D, et al. Amphetamine-associated ischemic stroke: clinical presentation and proposed pathogenesis. J Stroke Cerebrovasc Dis. 2007;16(4):185–6.CrossRef Silva D, Anne D, et al. Amphetamine-associated ischemic stroke: clinical presentation and proposed pathogenesis. J Stroke Cerebrovasc Dis. 2007;16(4):185–6.CrossRef
9.
go back to reference Dufour M, Payet C, Gillet A. Bilateral renal infarction and ecstasy. J Mal Vasc. 2014;39(4):285.CrossRef Dufour M, Payet C, Gillet A. Bilateral renal infarction and ecstasy. J Mal Vasc. 2014;39(4):285.CrossRef
10.
go back to reference Fleckenstein AE, et al. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007;47:681–98.CrossRef Fleckenstein AE, et al. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol. 2007;47:681–98.CrossRef
11.
go back to reference Fonseca AC, Ferro JM. Drug abuse and stroke. Curr Neurol Neurosci Rep. 2013;13(2):325.CrossRef Fonseca AC, Ferro JM. Drug abuse and stroke. Curr Neurol Neurosci Rep. 2013;13(2):325.CrossRef
12.
go back to reference Gebhard C, et al. Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4. Eur Heart J. 2010;31(14):1780–91.CrossRef Gebhard C, et al. Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4. Eur Heart J. 2010;31(14):1780–91.CrossRef
13.
go back to reference Gupta A, Kuperman M, Shah S. N-methylamphetamine (“Crystal Meth”)− Associated Acute Renal Cortical Necrosis. Kidney Int Rep. 2018;3(6):1473–6.CrossRef Gupta A, Kuperman M, Shah S. N-methylamphetamine (“Crystal Meth”)− Associated Acute Renal Cortical Necrosis. Kidney Int Rep. 2018;3(6):1473–6.CrossRef
14.
go back to reference Ho EL, et al. Cerebrovascular complications of methamphetamine abuse. Neurocrit Care. 2009;10(3):295–305.CrossRef Ho EL, et al. Cerebrovascular complications of methamphetamine abuse. Neurocrit Care. 2009;10(3):295–305.CrossRef
15.
go back to reference Huecker MR, Marraffa J. "Heroin." StatPearls: StatPearls Publishing; 2019. Huecker MR, Marraffa J. "Heroin." StatPearls: StatPearls Publishing; 2019.
16.
go back to reference Karch SB, Drummer O. Karch’s pathology of drug abuse: CRC press; 2008. Karch SB, Drummer O. Karch’s pathology of drug abuse: CRC press; 2008.
17.
go back to reference Khattab E, Shujaa A. Amphetamine abuse and acute thrombosis of left circumflex coronary artery. Int J Case Reports Images. 2013;4:698.CrossRef Khattab E, Shujaa A. Amphetamine abuse and acute thrombosis of left circumflex coronary artery. Int J Case Reports Images. 2013;4:698.CrossRef
18.
go back to reference Moqaddam AH, Musavi SMRA, Khademizadeh K. Relationship of opium dependency and stroke. Addiction Health. 2009;1(1):6. Moqaddam AH, Musavi SMRA, Khademizadeh K. Relationship of opium dependency and stroke. Addiction Health. 2009;1(1):6.
19.
go back to reference Ohta K, et al. Delayed ischemic stroke associated with methamphetamine use. J Emerg Med. 2005;28(2):165–7.CrossRef Ohta K, et al. Delayed ischemic stroke associated with methamphetamine use. J Emerg Med. 2005;28(2):165–7.CrossRef
20.
go back to reference Papachristidis A, et al. Aortic thrombus causing myocardial infarction after recreational MDMA use. Eur Heart J Cardiovasc Imaging. 2016;17(10):1187.CrossRef Papachristidis A, et al. Aortic thrombus causing myocardial infarction after recreational MDMA use. Eur Heart J Cardiovasc Imaging. 2016;17(10):1187.CrossRef
21.
go back to reference Reece AS, Hulse GK. Duration of opiate exposure as a determinant of arterial stiffness and vascular age in male opiate dependence: a longitudinal study. J Clin Pharm Ther. 2014;39(2):158–67.CrossRef Reece AS, Hulse GK. Duration of opiate exposure as a determinant of arterial stiffness and vascular age in male opiate dependence: a longitudinal study. J Clin Pharm Ther. 2014;39(2):158–67.CrossRef
22.
go back to reference Tatli E, Aktoz M. Heroin Abuse and Myocardial Infarction. Trakya Universitesi Tip Fakultesi Dergisi. 2010;27(2):212. Tatli E, Aktoz M. Heroin Abuse and Myocardial Infarction. Trakya Universitesi Tip Fakultesi Dergisi. 2010;27(2):212.
23.
go back to reference Weiss SR, et al. Intracerebral and subarachnoid hemorrhage following use of methamphetamine (" speed"). Int Surg. 1970;53(2):123.PubMed Weiss SR, et al. Intracerebral and subarachnoid hemorrhage following use of methamphetamine (" speed"). Int Surg. 1970;53(2):123.PubMed
24.
go back to reference Welling TH, Williams DM, Stanley JC. Excessive oral amphetamine use as a possible cause of renal and splanchnic arterial aneurysms: a report of two cases. J Vasc Surg. 1998;28(4):727–31.CrossRef Welling TH, Williams DM, Stanley JC. Excessive oral amphetamine use as a possible cause of renal and splanchnic arterial aneurysms: a report of two cases. J Vasc Surg. 1998;28(4):727–31.CrossRef
Metadata
Title
A rare case of renal infarction due to heroin and amphetamine abuse: case report
Authors
Suhail Khokhar
Daniela Garcia
Rajesh Thirumaran
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02642-1

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.